sábado, 17 de mayo de 2025

Sustained Bone Marrow and Imaging MRD Negativity for 3 Years Drives Discontinuation of Maintenance Post-ASCT in Myeloma

https://www.medscape.org/viewarticle/1002536

No hay comentarios:

Publicar un comentario